DIPK1A

Chr 1

divergent protein kinase domain 1A

Also known as: FAM69A

This gene encodes a cysteine-rich transmembrane protein that localizes to the endoplasmic reticulum, though its specific cellular function remains unknown. Mutations cause autosomal recessive spastic paraplegia with intellectual disability and seizures, typically with onset in early childhood. The gene shows moderate constraint against loss-of-function variants (LOEUF 0.494), suggesting intolerance to complete protein loss.

OMIMResearchSummary from RefSeq
MultiplemechanismLOEUF 0.49
Clinical SummaryDIPK1A
Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.58) — some intolerance to loss-of-function variants.
📋
ClinVar Variants
94 unique Pathogenic / Likely Pathogenic· 180 VUS of 409 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.49LOEUF
pLI 0.584
Z-score 2.97
OE 0.19 (0.090.49)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
2.26Z-score
OE missense 0.56 (0.490.66)
120 obs / 212.6 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.19 (0.090.49)
00.351.4
Missense OE0.56 (0.490.66)
00.61.4
Synonymous OE0.89
01.21.6
LoF obs/exp: 3 / 15.7Missense obs/exp: 120 / 212.6Syn Z: 0.72
DN
0.6162th %ile
GOF
0.4579th %ile
LOF
0.3454th %ile

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). The Badonyi & Marsh model scores dominant-negative highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF86% of P/LP variants are LoF · LOEUF 0.49
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

409 submitted variants in ClinVar

Classification Summary

Pathogenic64
Likely Pathogenic30
VUS180
Likely Benign93
Benign10
Conflicting10
64
Pathogenic
30
Likely Pathogenic
180
VUS
93
Likely Benign
10
Benign
10
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
53
1
10
0
64
Likely Pathogenic
28
1
1
0
30
VUS
3
159
16
2
180
Likely Benign
1
2
47
43
93
Benign
0
0
8
2
10
Conflicting
10
Total851638247387

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

DIPK1A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 1 results · since 2015Search PubMed ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found